NCT05783271 Validity of Parametric MRI Using VIRADS
| NCT ID | NCT05783271 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assiut University |
| Condition | Bladder Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 58 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 58 participants in total. It began in 2025-12-01 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Our aim in this prospective study is to evaluate the validity of the non-contrast biparametric MRI (bp-MRI), including T2-WI and DWI sequences, and the availability of an alternative to the mp-MRI, for the muscle invasiveness assessment of bladder cancer using VIRAD scoring in both techniques.
Eligibility Criteria
Inclusion Criteria: 58 cases of patients who suspected to have cancer urinary bladder by clinical, histopathological examination and radiological imaging. All age groups . Both sex Exclusion Criteria: patient with high renal chemistry. Patient with contraindications to MRI as pacemaker and cochlear implants. \-
Contact & Investigator
Hassan A.Abolella, Proff
PRINCIPAL INVESTIGATOR
Newvalley University
Frequently Asked Questions
Who can join the NCT05783271 clinical trial?
This trial is open to participants of all sexes, studying Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05783271 currently recruiting?
Yes, NCT05783271 is actively recruiting participants. Contact the research team at hasanibrahim48@yahoo.com for enrollment information.
Where is the NCT05783271 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT05783271 clinical trial?
NCT05783271 is sponsored by Assiut University. The principal investigator is Hassan A.Abolella, Proff at Newvalley University. The trial plans to enroll 58 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.